Ornithine Transcarbamylase (OTC) Treatment Market Share
4 mins read
Ornithine Transcarbamylase (OTC) Treatment Market: Emerging Factors, Future Demands, and Key Players
Global Ornithine Transcarbamylase (OTC) Treatment Market: Overview Ornithine transcarbamylase (OTC) deficiency, the most common urea cycle disorder, is caused by a genetic defect in a liver enzyme responsible for detoxification of ammonia, which is formed when proteins are broken down in the body. Individuals with OTC deficiency can build up excessive levels of ammonia, which […]